Radiation treatment planning using positron emission tomography for patients with non-small cell lung cancer;Planowanie radioterapii z wykorzystaniem pozytonowej tomografii emisyjnej u chorych na niedrobnokomórkowego raka płuca

Nowotwory

Volumn 56, Issue 3, 2006, Pages

  Lewandowska, Aleksandra ^a,b,c   Windorbska, Wiesława ^a,b   Morgaś, Tomasz ^a,b  

^a Cancer Center   (Poland)

^b Regional Oncology Centre Bydgoszcz   (Poland)

^c Regional Cancer Center   (Poland)

Author keywords

Non small cell lung cancer; Positron emission tomography; Radiation treatment planning

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ATELECTASIS; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; FIBROSIS; HUMAN; IMAGE ANALYSIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT PLANNING; TUMOR VOLUME;

EID: 33746253374     PISSN: 0029540X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Knight SB, Delbeke D, Stewart JR et al. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996; 109: 982-8.
2. Lowe VJ, Fletcher JW, Gobar L et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998; 16: 1075-84.
3. Imdahl A, Jenkner S, Brink I et al. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions. Eur J Cardio Thor Surg 2001; 20: 324-9.
4. Vansteenkiste JF, Mortelmans LA. FDG-PET in the locoregional lymph node staging of non-small cell lung cancer: a comprehensive review of the Leuven lung cancer group experience. Clin Pos Imag 1999; 2: 223-31.
5. Pieterman RM, Van Putten JW, Meuzelaar JJ et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000; 343: 254-61.
6. Lewis P, Griffin S, Marsden P et al. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cacer. Lancet 1994; 344: 1265-6.
7. Mac Manus MP, Hicks RJ, Matthews JP et al. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 2001; 50: 287-93.
8. Reske SN, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference "Onko-PET III". 21 July and 19 September 2000. Eur J Nucl Med 2001; 28: 1707-23.
9. Lardinois D, Weder W, Many TF et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348: 2500-7.
10. Vanuytsel LJ, Vansteenkiste JF, Stroobants SG et al. The impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 2000; 55: 317-24.
11. Bradley J, Thorstad WL, Mutic S et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004; 59: 78-86.
12. Giraud P, Grahek D, Montravers F et al. CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys 2001; 49: 1249-57.
13. Mah K, Caldwell CB, UNG YC et al. The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 2002; 52: 339-50.
14. Ciernik F, Dizendorf E, Baumert BG et al. Radiation treatment planning with an integrated positron emission and computed tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003; 57: 853-63.
15. Erdi YE, Rosenzweig K, Erdi AK et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002; 62: 51-60.
16. Caldwell CB, Mah K, Ung YC et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 2001; 51: 923-31.
17. Nestle U, Walter K, Schmidt S et al. 18F-Deoxyglucose Positron Emission Tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis.. Int J Radiat Oncol Biol Phys 1999; 44: 593-7.